Article Details
Retrieved on: 2021-04-25 07:07:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Ascendis Pharma A/S has a cash-to-debt ratio of 7.82, which is in the middle range of the companies in Biotechnology industry. The overall financial ...
Article found on: www.gurufocus.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here